Comparison of a topical benzoyl peroxide gel, oral minocycline, oral doxycycline and a combination for suppression of P-acnes in acne patients

被引:8
作者
Kligman, AM [1 ]
机构
[1] Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA
关键词
acne; minocycline-D; doxycycline; Propionibacterium acnes; benzoyl peroxide;
D O I
10.3109/09546639809160552
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Four groups of ten acne patients each received one of the following treatments for 1 month: (1) minocycline-'D', 100 mg twice daily; (2) doxycycline monohydrate, 100 mg twice daily; (3) 6% benzoyl peroxide-zinc gel twice daily; (4) minocycline-'D', 100 mg twice daily and 6% benzoyl peroxide-zinc gel twice daily Suppression of Propionibacterium acnes was assessed by the detergent scrub method after 2 and 4 weeks of treatment. Minocycline-'D' had a far greater ability to suppress P. acnes than doxycycline. Minocycline-'D' resulted in almost a 2-log decrease in P. acnes compared with less than 1-log decrease with doxycycline, Benzoyl peroxide-zinc gel was also more efficacious than doxy-cycline, As expected, the combination of minocycline-'D' and benzoyl peroxide-zinc gel was substantially more effective than the comparator treatments. The greater therapeutic efficacy of minocycline-'D' in acne cannot be fully explained by its antibacterial activity. Evidence is presented to show that minocycline has a wide spectrum of pharmacologic activities, including antiinflammatory effects, which explains its increasing therapeutic applications in a variety of unrelated disorders.
引用
收藏
页码:187 / 191
页数:5
相关论文
共 34 条
[1]   CONFLUENT AND RETICULATED PAPILLOMATOSIS (GOUGEROT-CARTEAUD) TREATED WITH TETRACYCLINES [J].
ANGELIBESSON, C ;
KOEPPEL, MC .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1995, 34 (08) :567-569
[2]   ANTIBIOTICS AND SUPPRESSION OF LYMPHOCYTE FUNCTION-INVITRO [J].
BANCK, G ;
FORSGREN, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (05) :554-560
[3]  
BEARD NS, 1969, PHARMACOL REV, V21, P213
[4]  
CELERIER P, 1990, ARCH DERMATOL RES, V288, P421
[5]   TETRACYCLINE AND ACNE-VULGARIS - CLINICAL AND LABORATORY INVESTIGATION [J].
CUNLIFFE, WJ ;
FORSTER, RA ;
GREENWOOD, ND ;
HETHERINGTON, C ;
HOLLAND, KT ;
HOLMES, RL ;
KHAN, S ;
ROBERTS, CD ;
WILLIAMS, M ;
WILLIAMSON, B .
BMJ-BRITISH MEDICAL JOURNAL, 1973, 4 (5888) :332-335
[6]   PYODERMA GANGRENOSUM - SUCCESSFUL TREATMENT WITH MINOCYCLINE [J].
DAVIES, MG ;
PIPER, S .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1981, 6 (02) :219-223
[7]  
DIAMPHONGSANT T, 1974, BRIT J DERMATOL, V91, P319
[8]   TETRACYCLINE-RESISTANT PROPIONIBACTERIA FROM ACNE PATIENTS ARE CROSS-RESISTANT TO DOXYCYLINE, BUT SENSITIVE TO MINOCYCLINE [J].
EADY, EA ;
JONES, CE ;
GARDNER, KJ ;
TAYLOR, JP ;
COVE, JH ;
CUNLIFFE, WJ .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 128 (05) :556-560
[9]   INVIVO SUPPRESSION OF NEUTROPHIL CHEMOTAXIS BY SYSTEMICALLY AND TOPICALLY ADMINISTERED TETRACYCLINE [J].
ELEWSKI, BE ;
LAMB, BAJ ;
SAMS, WM ;
GAMMON, WR .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1983, 8 (06) :807-812
[10]   Antimicrobial agents for the dermatologist .2. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin [J].
Epstein, ME ;
AmodioGroton, M ;
Sadick, NS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (03) :365-381